A retrospective study of tisagenlecleucel in patients with diffuse large B-cell lymphoma and B-acute lymphatic leukemia
Latest Information Update: 12 Jan 2023
At a glance
- Drugs Tisagenlecleucel (Primary)
- Indications Diffuse large B cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
Most Recent Events
- 12 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition